发明名称 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS.
摘要 <p>The invention relates to heterocyclic substituted amide derivatives of formula (I) that display selective binding to dopamine D 3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D 3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D 3 receptors.</p>
申请公布号 MXPA03006524(A) 申请公布日期 2003.09.25
申请号 MX2003PA06524 申请日期 2002.02.15
申请人 AVENTIS PHARMACEUTICALS INC. 发明人 JOHN G. JURCAK
分类号 C07D295/12;A61K31/33;A61K31/439;A61K31/4535;A61K31/454;A61K31/46;A61K31/495;A61K31/496;A61K31/497;A61K31/498;A61K31/502;A61K31/5377;A61K31/551;A61K45/00;A61K47/14;A61K47/44;A61K51/00;A61P13/12;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/28;A61P25/30;A61P43/00;C07D333/58;C07D333/66;C07D333/68;C07D333/70;C07D409/04;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D451/02;C07D471/04;C07D495/04;C07D498/04;C07D521/00;(IPC1-7):C07D409/00 主分类号 C07D295/12
代理机构 代理人
主权项
地址